Filing Details
- Accession Number:
- 0001209191-17-051084
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-01 19:19:23
- Reporting Period:
- 2017-09-01
- Accepted Time:
- 2017-09-01 18:19:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1001233 | Sangamo Therapeutics Inc | SGMO | Biological Products, (No Disgnostic Substances) (2836) | 680359556 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1691262 | Iii A. Curt Herberts | C/O Sangamo Therapeutics, Inc. Point Richmond Tech Ctr, 501 Canal Blvd. Richmond CA 94804 | Sr.vp & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-09-01 | 4,684 | $15.00 | 15,833 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-09-01 | 10,316 | $5.41 | 26,149 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-09-01 | 10,316 | $15.00 | 15,833 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-09-01 | 10,316 | $0.00 | 10,316 | $5.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,830 | 2022-12-05 | No | 4 | M | Direct |
Footnotes
- All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- The shares underlying the stock option are fully vested and exercisable.